Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
News
Browse
Subscribe

Conference News

SABCS 2019: Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer

(17 Dec 2019)

SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence

(16 Dec 2019)

SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breast cancer patients in phase III trial

(13 Dec 2019)

SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type

(13 Dec 2019)

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite effects on breast cancer incidence in postmenopausal women

(13 Dec 2019)

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer

(13 Dec 2019)

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive breast cancer

(13 Dec 2019)

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen alone

(13 Dec 2019)

SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer

(12 Dec 2019)

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients

(12 Dec 2019)

View all articles from the past year >

follow us

Immuno-oncology advances in cancer treatment e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation